Shodhana Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 15-12-2024
- Paid Up Capital ₹ 3.58 M
as on 15-12-2024
- Company Age 16 Year, 14 Days
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 0.60 M
as on 15-12-2024
- Revenue -89.08%
(FY 2017)
- Profit 26.66%
(FY 2017)
- Ebitda 46.89%
(FY 2017)
- Net Worth -6.73%
(FY 2017)
- Total Assets -20.62%
(FY 2017)
About Shodhana Biotech
The Company is engaged in the Research & Development Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.58 M.
The company has closed loans amounting to ₹0.60 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Guttula Sathyanarayanarao, Subramanian Srinivasan, Addicam Rao, and One other member serve as directors at the Company.
- CIN/LLPIN
U73200KA2008PTC048522
- Company No.
048522
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
05 Dec 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shodhana Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Guttula Sathyanarayanarao  | Managing Director | 05-Dec-2008 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Subramanian Srinivasan | Director | 10-Aug-2010 | Current |
| Addicam Rao | Director | 15-Nov-2010 | Current |
| Udayakumar Rakkasagi | Director | 02-Sep-2024 | Current |
Financial Performance and Corporate Structure Insights of Shodhana Biotech.
Shodhana Biotech Private Limited, for the financial year ended 2017, experienced significant reduction in revenue, with a 89.08% decrease. The company also saw a substantial improvement in profitability, with a 26.66% increase in profit. The company's net worth dipped by a decrease of 6.73%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shodhana Biotech?
In 2017, Shodhana Biotech had a promoter holding of 61.92% and a public holding of 38.08%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vasudev Adigas Fastfood Private LimitedActive 17 years 2 monthsUdayakumar Rakkasagi is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Karnataka Bank Limited Creation Date: 21 Feb 2014 | ₹0.60 M | Satisfied |
How Many Employees Work at Shodhana Biotech?
Unlock and access historical data on people associated with Shodhana Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shodhana Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shodhana Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
